Press Releases

Press Releases

May 08, 2023

CRISPR Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results

May 02, 2023

CRISPR Therapeutics to Participate Upcoming Investor Conferences

Apr 13, 2023

CRISPR Therapeutics to Participate in Needham’s 22nd Annual Healthcare Conference

Apr 03, 2023

CRISPR Therapeutics and Vertex Complete Submission of Rolling Biologics License Applications (BLAs) to the US FDA for exa-cel for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia

Mar 29, 2023

CRISPR Therapeutics Announces Departure of Board Member

Mar 27, 2023

CRISPR Therapeutics and Vertex Announce Licensing Agreement to Accelerate Development of Vertex’s Hypoimmune Cell Therapies for the Treatment of Type 1 Diabetes

Mar 14, 2023

CRISPR Therapeutics to Present at the American Association for Cancer Research 2023 Annual Meeting

Mar 13, 2023

CRISPR Therapeutics Announces Transition of Chief Financial Officer

Feb 27, 2023

CRISPR Therapeutics to Participate in the 43rd Annual Cowen Health Care Conference

Feb 21, 2023

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results

Feb 08, 2023

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

Jan 11, 2023

CRISPR Therapeutics to Participate in B. Riley Securities’ 3rd Annual Oncology Conference